Brochure | April 14, 2022

GenVoy-ILM™ T Cell Kit For mRNA On NanoAssemblr® Spark™

Source: Cytiva
1

Lipid Nanoparticle (LNP) based technology enables researchers to establish a clinically relevant, scalable method for ex vivo gene delivery to advance the development of cell therapies.

The GenVoy-ILM™ T Cell Kit for mRNA is an LNP reagent mix. This kit is optimized for the delivery of mRNA into activated primary human T cells using mRNA-LNPs formulated on the NanoAssemblr® Spark™ instrument and cartridges.

access the Brochure!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.

Subscribe to Advancing RNA X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Advancing RNA

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Cytiva